Drug and Venom Allergy in Mastocytosis

被引：7

作者：

Giannetti, Matthew P. ^{[1
,2
,4
]}

Nicoloro-SantaBarbara, Jennifer ^{[2
,3
]}

Godwin, Grace ^{[1
]}

Middlesworth, Julia ^{[1
]}

Espeland, Andrew ^{[1
]}

Castells, Mariana C. ^{[1
,2
]}

机构：

[1] Brigham & Womens Hosp, Div Allergy & Clin Immunol, 41 Ave Louis Pasteur,Alumni Hall,Room 303, Boston, MA 02115 USA

[2] Harvard Med Sch, 41 Ave Louis Pasteur,Alumni Hall,Room 303, Boston, MA 02115 USA

[3] Brigham & Womens Hosp, Dept Psychiat, 41 Ave Louis Pasteur,Alumni Hall,Room 303, Boston, MA 02115 USA

[4] Brigham & Womens Hosp, Div Allergy & Clin Immunol, 60 Fenwood Rd,Hale Bldg Transformat Med,5th floor, Boston, MA 02132 USA

来源：

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2023年 / 43卷 / 04期

关键词：

Nonsteroidal antiinflammatory drugs (NSAIDs); Antibiotics; Vaccines; Perioperative anaphylaxis; MAST-CELL ACTIVATION; SPANISH NETWORK; TRYPTASE LEVELS; SYSTEMIC MASTOCYTOSIS; INDUCED ANAPHYLAXIS; CLINICAL-FEATURES; RISK; IMMUNOTHERAPY; DISORDERS; HYPERSENSITIVITY;

D O I：

10.1016/j.iac.2023.04.002

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

"I would like to challenge you with ibuprofen and if you have no reaction, I will remove the label of "Allergy to NSAIDS." You may take aspirin, ibuprofen, and other drugs needed for arthritis. Protocols for skin testing and challenges leading to drug delabeling of mastocytosis patients are needed.Although some patients with mastocytosis need protection when exposed to NSAIDs, opioids, vaccines, antibiotics, and RCM, better diagnostic tools are needed to assess the populations at risk. Personalized diagnosis should be provided to patients aimed at labeling and delabeling drugs allergies. Patients with mastocytosis should be evaluated for tolerance to drugs before acute situations, particularly children and pregnant women.New therapies such as tyrosine kinase inhibitors hope to address the number and activation of mast cells and are currently in clinical trials. Whether such medications would improve tolerance of drugs-inducing reactions will need to be addressed.

引用

页码：699 / 710

页数：12

共 60 条

[1] Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis [J].

Alvarez-Twose, I. ;

Vano-Galvan, S. ;

Sanchez-Munoz, L. ;

Morgado, J. M. ;

Matito, A. ;

Torrelo, A. ;

Jaen, P. ;

Schwartz, L. B. ;

Orfao, A. ;

Escribano, L. .

ALLERGY, 2012, 67 (06) :813-821

[2] Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM [J].

Alvarez-Twose, Ivan ;

Zanotti, Roberta ;

Gonzalez-de-Olano, David ;

Bonadonna, Patrizia ;

Vega, Arantza ;

Matito, Almudena ;

Sanchez-Munoz, Laura ;

Mario Morgado, Jose ;

Perbellini, Omar ;

Garcia-Montero, Andres ;

De Matteis, Giovanna ;

Teodosio, Cristina ;

Rossini, Maurizio ;

Jara-Acevedo, Maria ;

Schena, Donatella ;

Mayado, Andrea ;

Zamo, Alberto ;

Mollejo, Manuela ;

Sanchez-Lopez, Paula ;

Cabanes, Nieves ;

Orfao, Alberto ;

Escribano, Luis .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) :520-+

[3] Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms [J].

Alvarez-Twose, Ivan ;

Gonzalez de Olano, David ;

Sanchez-Munoz, Laura ;

Matito, Almudena ;

Esteban-Lopez, Maria I. ;

Vega, Arantza ;

Belen Mateo, Maria ;

Alonso Diaz de Durana, Maria D. ;

de la Hoz, Belen ;

del Pozo Gil, Maria D. ;

Caballero, Teresa ;

Rosado, Ana ;

Sanchez Matas, Isabel ;

Teodosio, Cristina ;

Jara-Acevedo, Maria ;

Mollejo, Manuela ;

Garcia-Montero, Andres ;

Orfao, Alberto ;

Escribano, Luis .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (06) :1269-1278

[4]

Aun MV, 2014, J ALLER CL IMM-PRACT, V2, P826, DOI [10.1016/j.jaip.2014.03.014, 10.1016/j.jaip.2014.08.015]

[5] Generalized Bullous Eruption after Routine Vaccination in a Child with Diffuse Cutaneous Mastocytosis [J].

Bankova, Lora G. ;

Walter, Jolan E. ;

Iyengar, Shuba R. ;

Lorenzo, Mayra E. ;

Hornick, Jason L. ;

Castells, Mariana C. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2013, 1 (01) :94-96

[6] Successful administration of omali zumab by desensitization protocol following systemic reactions in 12 patients [J].

Bernaola, Marta ;

Hamadi, Sahar A. ;

Lynch, Donna-Marie ;

Marquis, Kathleen A. ;

Silver, Jared N. ;

Castells, Mariana C. ;

Hsu, Joyce T. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (06) :2505-+

[7] Opioid-induced mast cell activation and vascular responses is not mediated by μ-opioid receptors:: An in vivo microdialysis study in human skin [J].

Blunk, JA ;

Schmelz, M ;

Zeck, S ;

Skov, P ;

Likar, R ;

Koppert, W .

ANESTHESIA AND ANALGESIA, 2004, 98 (02) :364-370

[8] Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper [J].

Bonadonna, P. ;

Pagani, M. ;

Aberer, W. ;

Bilo, M. B. ;

Brockow, K. ;

Elberink, H. Oude ;

Garvey, L. ;

Mosbech, H. ;

Romano, A. ;

Zanotti, R. ;

Torres, M. J. .

ALLERGY, 2015, 70 (07) :755-763

[9]

Bonadonna P, 2014, J INVEST ALLERG CLIN, V24, P288

[10] COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM) [J].

Bonadonna, Patrizia ;

Brockow, Knut ;

Niedoszytko, Marek ;

Elberink, Hanneke Oude ;

Akin, Cem ;

Nedoszytko, Boguslaw ;

Butterfield, Joseph H. ;

Alvarez-Twose, Ivan ;

Sotlar, Karl ;

Schwaab, Juliana ;

Jawhar, Mohamad ;

Castells, Mariana ;

Sperr, Wolfgang R. ;

Hermine, Olivier ;

Gotlib, Jason ;

Zanotti, Roberta ;

Reiter, Andreas ;

Broesby-Olsen, Sigurd ;

Bindslev-Jensen, Carsten ;

Schwartz, Lawrence B. ;

Horny, Hans-Peter ;

Radia, Deepti ;

Triggiani, Massimo ;

Sabato, Vito ;

Carter, Melody C. ;

Siebenhaar, Frank ;

Orfao, Alberto ;

Grattan, Clive ;

Metcalfe, Dean D. ;

Arock, Michel ;

Gulen, Theo ;

Hartmann, Karin ;

Valent, Peter .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (06) :2139-2144

← 1 2 3 4 5 6 →